Skip to content

KULR Technology Group KULR Grant — Revenue Not From Contract With Customer

Similar metrics at other companies

Kopin logo
KOPNGrant — Revenue
$3.44M+1,505%
Celldex Therapeutics logo
CLDXGrant — Revenue
$15K-97.7%
CRISPR Therapeutics logo
CRSPGrant — Revenue
$458K-47.1%
Kopin logo
KOPNGrant Income — Revenue
$3.44M+1,504%
Recursion Pharmaceuticals, Inc. logo
RXRXGrant revenue — Revenue from Contract with Customer, Excluding Assessed Tax
$171K+334%
Organogenesis Holdings Inc. logo
ORGOGrant — Revenue
$978K

Other financials

Income statement

See full
Revenue$4.8M+97.9%
Gross profit$1.4M+587%
Operating income-$7.4M+21.8%
Net income-$28.1M-49.5%
EPS (diluted)-$0.61-13.0%

Balance sheet

See full
Cash & equivalents$7.7M-68.6%
Total debt$1.4M+13.5%
Total equity$94.6M+5.5%
Total assets$105.5M+12.5%

Cash flow

See full
Operating cash flow-$8.7M+9.6%
CapEx$173.6K+44.4%
Free cash flow-$8.9M+8.9%

Valuation

See full
Market cap$176.24M-10.2%
Enterprise value$169.92M-4.3%
P/S9.5×-5.6×

Profitability

See full
Gross margin22.1%-19.3pp
Operating margin-220.5%+77.3pp
Net margin-383.5%+256pp
FCF margin-253.1%+71.2pp

Returns & leverage

See full
Return on equity-77.3%+12.4pp
Debt / equity0.0×
Current ratio1.7×-7.5×

Where this comes from

Reported directly by KULR Technology Group in its filing.

Tagged under the XBRL concept us-gaap:RevenueNotFromContractWithCustomer.

The official record: KULR Technology Group’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about KULR Technology Group's grant — revenue not from contract with customer.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KULR Technology Group's grant — revenue not from contract with customer?
KULR Technology Group (KULR) reported grant — revenue not from contract with customer of $1.37M in Q1 2026.
What does grant — revenue not from contract with customer mean?
This metric represents income recognized by the company that is derived from sources other than standard commercial customer contracts, such as government grants or non-exchange transactions. It reflects the company's ability to secure non-dilutive funding or subsidies to support its operational activities. Investors use this to assess the scale of external financial support independent of core product sales.